Ropinirole in the Treatment of Bipolar Depression
Phase 4
Completed
- Conditions
- Bipolar Disorder
- First Posted Date
- 2006-04-17
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Cambridge Health Alliance
- Target Recruit Count
- 40
- Registration Number
- NCT00314821
- Locations
- ๐บ๐ธ
Emory University, Atlanta, Georgia, United States
๐บ๐ธCambridge Health Alliance, Cambridge, Massachusetts, United States
An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders
Phase 2
Completed
- Conditions
- AutismPervasive Developmental DisorderAsperger's Disorder
- Interventions
- First Posted Date
- 2006-03-29
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- Cambridge Health Alliance
- Target Recruit Count
- 14
- Registration Number
- NCT00308074
- Locations
- ๐บ๐ธ
Cambridge Health Alliance, Medford, Massachusetts, United States
Depakote-ER for Depressive and Bipolar Depression
Phase 4
Completed
- Conditions
- Bipolar Disorder
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Cambridge Health Alliance
- Target Recruit Count
- 25
- Registration Number
- NCT00226343
Natural Supplements for Unipolar Depression
Phase 4
Completed
- Conditions
- Unipolar Depression
- Interventions
- Drug: Supplements of L-methionine, betaine and folate
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Cambridge Health Alliance
- Target Recruit Count
- 20
- Registration Number
- NCT00226356
- Locations
- ๐บ๐ธ
Cambridge Health Alliance, Cambridge, Massachusetts, United States
Aripiprazole in the Treatment of Bipolar Depression
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Cambridge Health Alliance
- Target Recruit Count
- 20
- Registration Number
- NCT00226317
- Locations
- ๐บ๐ธ
Cambridge Health Alliance, Cambridge, Massachusetts, United States
A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Cambridge Health Alliance
- Target Recruit Count
- 30
- Registration Number
- NCT00195845
- Locations
- ๐บ๐ธ
Cambridge Health Alliance, Cambridge, Massachusetts, United States
The Trauma Recovery and Resiliency Research Project
Completed
- Conditions
- Posttraumatic Stress Disorders
- First Posted Date
- 2005-08-18
- Last Posted Date
- 2017-04-18
- Lead Sponsor
- Cambridge Health Alliance
- Target Recruit Count
- 969
- Registration Number
- NCT00131534
- Locations
- ๐บ๐ธ
Victims of Violence Program, Cambridge Health Alliance, Somerville, Massachusetts, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath